-+ 0.00%
-+ 0.00%
-+ 0.00%

ARTIVA BIOTHERAPEUTICS ANNOUNCES MULTIPLE ALLONK® DATA PRESENTATIONS AT EULAR 2026 CONGRESS, INCLUDING LATE-BREAKING ORAL PRESENTATION HIGHLIGHTING CLINICAL EFFICACY COMPARABLE TO AUTOLOGOUS CAR T-CELL THERAPY IN RHEUMATOLOGIC DISEASES

Reuters·05/19/2026 20:05:01

Please log in to view news